NeuroTherapeutics Pharma secures $43 million in Series B round of financing - MarketLine Financial Deals

NeuroTherapeutics Pharma secures $43 million in Series B round of financing

NeuroTherapeutics Pharma secures $43 million in Series B round of financing - MarketLine Financial Deals
NeuroTherapeutics Pharma secures $43 million in Series B round of financing
Published May 20, 2010
4 pages — Published May 20, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

NeuroTherapeutics Pharma, Inc., a US-based biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, has secured $43 million in Series B round of financing led by SR One, a venture arm of GlaxoSmithKline plc, followed by Fidelity Biosciences, MPM Capital and Pfizer, Inc.

  
Source:
Document ID
MA25388_100524
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "NeuroTherapeutics Pharma secures $43 million in Series B round of financing" May 20, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NeuroTherapeutics-Pharma-secures-43-million-in-Series-B-round-of-financing-2052-33330>
  
APA:
MarketLine Financial Deals. (2010). NeuroTherapeutics Pharma secures $43 million in Series B round of financing May 20, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/NeuroTherapeutics-Pharma-secures-43-million-in-Series-B-round-of-financing-2052-33330>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.